[Federal Register Volume 62, Number 60 (Friday, March 28, 1997)]
[Notices]
[Pages 14944-14945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-7879]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on November 22, 1996, Johnson &
Johnson Pharmaceutical Partners, HC-02 State Road 933, KMO.1 Mamey
Ward, HC-02 Box 19250, Gurabo, Puerto Rico 00778-
[[Page 14945]]
9629, made application by renewal, which was received for processing
February 14, 1997, to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of sufentanil (9740), a basic class
of controlled substance in Schedule II.
The firm plans to manufacture the listed controlled substance for
bulk distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substance may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than May 27, 1997.
Dated: February 28, 1997.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 97-7879 Filed 3-27-97; 8:45 am]
BILLING CODE 4410-09-M
